GlassScriptPhysician profile
Joshua A Tarpley
NPI 1790179935
$3,165.95
in general payments reported to CMS, 2019-2025
21 companies · $705 in 2025
The $705 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $459 · 2021: $526 · 2022: $474 · 2023: $301 · 2024: $281 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258 · Travel and Lodging: $28.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.14 |
| Travel and Lodging | $28.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $840.22 | 2019-2025 | |
| Pfizer INC. | $595.93 | 2019-2025 | |
| Glaxosmithkline, LLC. | $530.06 | 2019-2025 | Shingrix, Arexvy |
| Abbvie INC. | $343.43 | 2025 | |
| Janssen Pharmaceuticals, INC | $160.90 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $132.12 | 2020-2021 | |
| Abiomed | $94.92 | 2022-2024 | Impella |
| Amgen INC. | $78.32 | 2019 | |
| Hikma Pharmaceuticals USA | $46.65 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.69 | 2022 | |
| Genentech USA, INC. | $42.50 | 2019-2020 | |
| Exact Sciences Corporation | $41.72 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $38.30 | 2023-2025 | Eterna |
| Boston Scientific Corporation | $32.96 | 2021 | |
| Phathom Pharmaceuticals, INC. | $30.14 | 2025 | Voquezna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $29.59 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.87 | 2023 | |
| Vanda Pharmaceuticals INC. | $17.68 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $16.93 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.85 | 2023 | Quviviq |
| Lilly USA, LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Tarpley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.